Aytu BioScience

AYTU NASDAQ
1.354
-0.051
-3.62%
交易中 09:42 08/21 EDT
开盘
1.420
昨收
1.405
最高
1.420
最低
1.334
成交量
5,850
成交均量(3M)
18.78万
52周最高
4.800
52周最低
0.6800
换手率
0.04%
市值
2,256.15万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aytu BioScience AYTU股票价格,Aytu BioScience股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
展开 >

最近浏览

名称
价格
涨跌幅